Ribo Medicine - moving to bluesky

I am moving this account to: @ribomedicine.bsky.social

No more posts here.

Research team of Tom Roberts @UniofOxford

[Ribo Medicine - moving to bluesky @RiboMedicine]

I am moving my account to bluesky: @ribomedicine.bsky.social

[Ribo Medicine - moving to bluesky @RiboMedicine]

Latest research from my group. An N-glycosylated protein, PTTG1IP, can be utilised to load extracellular vesicles with therapeutic cargo molecules. @IdrmOxford @OxPaediatrics @OxfordDPAG
https://t.co/lByRlMd07V

[Kenneth W Witwer (he/him) @KennethWWitwer]

In fifth, Tom Roberts of the @RiboMedicine lab shared an important cautionary note on non-EV materials that may be present in growth media: "EV-mediated promotion of myogenic differentiation is dependent on dose, collection medium, and isolation method" https://t.co/wkML385JOO

[Ribo Medicine - moving to bluesky @RiboMedicine]

A discussion on the therapeutic landscape for Duchenne muscular dystrophy @IdrmOxford @OxPaediatrics #DMD #Duchenne #exonskipping #dystrophin #genetherapy https://t.co/s4hzKdMLWs

[Ribo Medicine - moving to bluesky @RiboMedicine]

Here is the paper from @KevinMFlanigan lab: https://t.co/PvTiQ3gzeB

[Ribo Medicine - moving to bluesky @RiboMedicine]

A brief commentary that I wrote for @MolTherapy Methods & Clinical Development on exon skipping therapy for DMD patients with exon 2 duplications @KevinMFlanigan @IdrmOxford @OxPaediatrics #DMD #exonskipping #Duchenne https://t.co/xJYh05cKpK

[Ribo Medicine - moving to bluesky @RiboMedicine]

My recent talk for the #EVClub describing our recent work on #ExtracellularVesicles, #miRNAs, and #muscle. https://t.co/aC6YI9hsU0 @Idrm @IsevOrg

[Kenneth W Witwer (he/him) @KennethWWitwer]

What else is in our preparations of #ExtracellularVesicles? Might these co-isolates contribute to effects of an #EVPreparation? Join #EVClub with Tom Roberts this week to learn more about the importance of "dose, collection medium, and isolation method"
Wed 11 Oct 12 noon EDT/5 PM UK/18.00 CEST
Need the login? https://t.co/rlKrHe0rTg
See the paper: https://t.co/i7NuChCjjF
@IdrmOxford @RiboMedicine @IsevOrg @IsevComms @LabWitwer

[Nature Reviews Drug Discovery @NatRevDrugDisc]

For readers interested in the pipeline of therapeutics for Duchenne muscular dystrophy, here's a comprehensive review that has just been published https://t.co/fDM9pnfyfy

[Ribo Medicine - moving to bluesky @RiboMedicine]

My recent review of the therapeutic landscape for Duchenne muscular dystrophy, focusing on dystrophin restoration therapies @IdrmOxford @OxPaediatrics #DMD #Duchenne #dystrophin https://t.co/U1xAVf3olq

[Ribo Medicine - moving to bluesky @RiboMedicine]

Latest preprint article from my group: An extracellular vesicle delivery platform based on the PTTG1IP protein https://t.co/ZkWrVTN7oy

[Ribo Medicine - moving to bluesky @RiboMedicine]

Latest work from my group on the role of EVs in myogenic differentiation out now in #MTNA. #IdrmOxford #OxPaediatrics https://t.co/1abjVx9SLJ

[Ribo Medicine - moving to bluesky @RiboMedicine]

I was featured on the @IdrmOxford website member of the month feature https://t.co/PkLd0v71Sm

[Ribo Medicine - moving to bluesky @RiboMedicine]

Congratulations to my student Kasia Chwalenia - awarded an abstract prize at the @OxPaediatrics DPhil day @IdrmOxford @KChwalenia

[Ribo Medicine - moving to bluesky @RiboMedicine]

Some more press from @MDUK_News related to the Town and Gown 10k run last weekend @IdrmOxford
https://t.co/duCYTftTyN

[Ribo Medicine - moving to bluesky @RiboMedicine]

Thanks to all the runners, volunteers, and supporters at the Oxford Town and Gown 10k in support of Muscular Dystrophy UK! @MDUK_News @IdrmOxford

[Ribo Medicine - moving to bluesky @RiboMedicine]

Latest @biorxivpreprint preprint from @AndaloussiLab in collaboration with our group: Multimodal engineering of extracellular vesicles for efficient intracellular protein delivery https://t.co/EKihOpAX4k @IdrmOxford

[Ribo Medicine - moving to bluesky @RiboMedicine]

Recent work from our our group led by Dr Yulia Lomonosova on the role of eEF2k/eEF2 in disuse atrophy https://t.co/beoSu5Px5x @IdrmOxford @CatherynLim88

[Ribo Medicine - moving to bluesky @RiboMedicine]

Some local media coverage of our upcoming involvement in the MDUK 10k run - fundraising for muscular dystrophy research @MDUK_News @IdrmOxford https://t.co/rKlueUw1Aj

[Oxford_IDRM @IdrmOxford]

IDRM Researcher Tom Roberts @RiboMedicine is one of our many researchers joining the Oxford Town and Gown 10k event, on Sunday 14 May. @MDUK_News

To read more: https://t.co/vQQVNIobTB